CONMED Corporation
CNMD
$33.97
-$0.81-2.32%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -53.81% | -64.47% | -51.37% | 11.77% | 44.20% |
| Total Depreciation and Amortization | 4.24% | 3.72% | 2.69% | 1.93% | 0.56% |
| Total Amortization of Deferred Charges | -6.40% | -3.58% | -6.77% | -5.83% | -6.83% |
| Total Other Non-Cash Items | 324.86% | 1,777.62% | 329.36% | 91.97% | -31.55% |
| Change in Net Operating Assets | -32.39% | 71.17% | -90.06% | -312.86% | -61.32% |
| Cash from Operations | -20.49% | 2.23% | -6.85% | -5.57% | 13.31% |
| Capital Expenditure | -27.59% | -51.38% | -34.79% | -6.89% | 11.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -335.29% | -- | -- | -- | 185.00% |
| Cash from Investing | 0.42% | -60.17% | -28.68% | -1.53% | 21.53% |
| Total Debt Issued | 10.81% | -4.04% | -12.46% | -19.45% | -14.23% |
| Total Debt Repaid | -0.53% | 3.37% | 9.66% | 17.06% | 10.35% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 24.77% | -0.39% | -0.44% | -0.41% | -0.49% |
| Other Financing Activities | -12.17% | 32.87% | 41.11% | 35.56% | -28.93% |
| Cash from Financing | 19.96% | 10.05% | 5.78% | 7.81% | -22.28% |
| Foreign Exchange rate Adjustments | 158.46% | 189.86% | -67.29% | 183.33% | -301.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -127.91% | 9,935.58% | -94.20% | 396.18% | -77.86% |